Gestational diabetes mellitus (GDM) is one of the most common health complications during pregnancy, affecting many expecting parents. Effective blood sugar control is crucial for the health of both the parent and the baby. One in four individuals with GDM may need medication to manage their blood sugar effectively.
Traditionally, insulin injections have been the go-to treatment for GDM. However, an oral medication called metformin is becoming a popular alternative. Both options can help lower pregnancy risks, but more research is needed to compare how well they work for different groups of people in the U.S.
A new study aims to fill this gap. Researchers will conduct a clinical trial to see if metformin is as effective and safe as insulin for reducing risks during pregnancy. The study will also explore the experiences of individuals with GDM regarding both treatments, looking at what helps or hinders their use of metformin and insulin.
The study will involve 1,572 pregnant individuals with GDM from 20 sites across the U.S. Participants will receive consistent care for either metformin or insulin, and researchers will follow them and their children from pregnancy through two years after delivery.
For more information about the study, visit www.decidestudy.org.